Risperidone controlled-release - Delpor

Drug Profile

Risperidone controlled-release - Delpor

Alternative Names: DLP-114

Latest Information Update: 31 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Delpor
  • Class Antineoplastics; Antipsychotics; Isoxazoles; Piperidines; Pyrimidinones; Small molecules
  • Mechanism of Action Dopamine D2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes - Schizophrenia

Highest Development Phases

  • Preclinical Bipolar disorders; Schizophrenia

Most Recent Events

  • 31 Aug 2017 Delpor plans a phase I trial in Healthy volunteers in Australia (ACTRN12617001251314)
  • 16 Aug 2016 Chemical structure information added
  • 15 Aug 2016 Risperidone controlled-release - Delpor is available for licensing as of 15 Aug 2016. http://www.delpor.com/
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top